JANE STREET GROUP, LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 69 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$32,601
-41.1%
13,992
-39.9%
0.00%
Q2 2023$55,371
-68.6%
23,265
-75.7%
0.00%
Q1 2023$176,412
+330.3%
95,876
+397.1%
0.00%
Q3 2022$41,000
-2.4%
19,289
+31.1%
0.00%
Q2 2022$42,000
-39.1%
14,717
+10.2%
0.00%
Q4 2021$69,000
-64.8%
13,352
-54.9%
0.00%
Q2 2021$196,000
-10.1%
29,588
+117.7%
0.00%
Q2 2020$218,00013,5900.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,283,966$15,166,0001.40%
Sio Capital Management, LLC 591,870$3,930,0000.98%
TFG Asset Management GP Ltd 2,500,000$16,600,0000.90%
Ikarian Capital, LLC 1,356,048$9,004,0000.73%
SABBY MANAGEMENT, LLC 400,050$2,656,0000.37%
Nantahala Capital Management 1,793,500$11,909,0000.34%
Regency Capital Management Inc.\DE 57,000$378,0000.29%
Eversept Partners, LP 473,074$3,141,2110.21%
MYDA Advisors LLC 85,000$564,0000.14%
Henry James International Management Inc. 54,047$359,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders